J
Tierney, Lawrence M., McPhee, Stephen J., Papadakis, Maxine A.
Current Medical Diagnosis & Treatment, 45th Edition
document.getElementById('working').innerHTML = ''; function hide_scrollbar() { var e = document.body; e.style.scrollbarBaseColor = '#fff'; e.style.scrollbarArrowColor = '#fff'; e.style.scrollbarDarkShadowColor = '#fff'; e.style.scrollbarShadowColor = '#fff'; } function show_scrollbar() { var e = document.body; e.style.scrollbarBaseColor = '#ccc'; e.style.scrollbarArrowColor = '#000'; e.style.scrollbarDarkShadowColor = '#000'; e.style.scrollbarShadowColor = '#666'; } function toggle_CA(e) { var src; src = window.parent.getSrc(e); if (src.nextSibling.style.display == 'block') { src.nextSibling.style.display='none'; src.innerHTML='View Answer'; } else { src.nextSibling.style.display='block'; src.innerHTML='Hide Answer'; } } function resolve_link(e,setid,locator,dbid,toan) { e.href = "ovidweb.cgi?S=IDNJHKIDOHDOJK00D;FTS+Link+Set+Ref=" + setid + "|" + locator + "|" + dbid + "|" + toan; return true; }
N
N-3 (omega-3) fatty acids, in heart disease prevention 340
Na+ See Sodium
Nab-paclitaxel ABI-007 1662 1674
Nabumetone 76
Nadolol 432
breast feeding and 786
Nadroparin, for venous thrombosis/pulmonary embolism
in prevention 287
in treatment 288
Naegleria fowleri 1295 1472 1473
Nafarelin, for endometriosis 740
Nafcillin 1564
cost of 1561
therapy adjustments in renal or hepatic failure and 1559
toxicity of 1565
NAFLD See Nonalcoholic fatty liver disease
Naftifine 89
Naftin See Naftifine
Nail atrophy 145
Nail disorders 145–146
candidal infection 121 145
hyperpigmentation, drugs causing 145 149 1100
pitting/stippling 145
in psoriasis 97 145
tinea unguium (onychomycosis) 145 146
Nalfon See Fenoprofen
Nalidixic acid 1579
Nalmefene, for opioid overdose 1611
Naloxone
for coma 1017 1608
for opioid overdose/withdrawal 1087 1608 1611 1631
for respiratory acidosis 893
Naltrexone
for alcohol use/abuse 1085
for opioid withdrawal 1087
Nanoparticle paclitaxel ABI-007 1662 1674
Nanoparticles, MRI with, in cancer imaging 1658
P.1833
Naphazoline 789
overdose/toxicity of 1623
Naprosyn See Naproxen
Naproxen 76
for pain management 76
Narcissistic personality disorder 1055
Narcolepsy 1080
Narcosis, carbon dioxide, in respiratory acidosis 893
Narcotic (opioid) antagonists See also Naloxone
for coma 1017 1608
for opioid overdose/withdrawal 1087 1608
Narcotics See Opioids/opioid analgesics
Nardil See Phenelzine
Nasal CPAP, for sleep apnea 306
Nasal polyps 200
in allergic rhinitis 197 200
Nasal pyramid, fracture of 199
Nasal septoplasty, for sleep apnea 306
Nasal sinuses See Paranasal sinuses
Nasal trauma 199–200
epistaxis and 199
Nasal tumors 200–202
Epstein-Barr virus and 201 1359
Nasal vestibulitis 197
NASH See Nonalcoholic steatohepatitis
Nasoduodenal feeding tube 1280
Nasogastric intubation
for feeding tube 1280
for gastric outlet obstruction 594
for gastrointestinal bleeding 552 555
for near drowning victim 1602
for vomiting 538
Nasolacrimal duct, obstruction of, dacryocystitis and 155
Nasopharynx
juvenile angiofibroma arising in 200–201
malignant tumors of 201
Epstein-Barr virus and 201 1359
serous otitis media and 184
in paracoccidioidomycosis 1546
Natacyn See Natamycin
Natalizumab, for multiple sclerosis 1015
Natamycin 1583
for ophthalmic disorders 176 1583
Nateglinide 1207 1209
Native DNA, antibodies to 836
Natriuresis defects, in hypertension 422
Natriuretic peptide
atrial, in cardiac failure 386
B-type (BNP)
in cardiac failure 312–313 389
in dyspnea 24
recombinant See Nesiritide
Nausea and vomiting 538–540 539 540
acupuncture for 1726 1728–1729
in appendicitis 612 613
chemotherapy-induced 539 1682–1683
acupuncture for 1728–1729
drugs for management of 540 540
in HIV infection/AIDS 1322
in intestinal obstruction 539
in intracerebral hemorrhage 995
in migraine headache 539 975
opioids causing 79
in pancreatitis 539 694 698
in pregnancy 538 767
acupuncture for 1728–1729
in gestational trophoblastic disease 773
in subarachnoid hemorrhage 995
in terminally ill/dying patient 80–81
in vertigo 190
Navane See Thiothixene
Navy top tubes 1743
Nd:YAG laser photoresection See also Laser therapy
for esophageal cancer palliation 578
for lung cancer palliation 271
Near drowning 1601–1603
Nebulizer therapy, for asthma 231 234 237
Necator americanus 1525 1526
Neck
in HIV infection/AIDS 217
infections of
deep 207
masses caused by 215–216
masses in 214–216
carotid artery aneurysm 458
carotid body tumors 458
congenital lesions presenting as 215
in Hodgkin's disease 514
infectious and inflammatory 215–216
lymphoma 216
metastatic 216
thyroid cancer See Thyroid gland, cancer of
Neck dissection, for thyroid cancer 1126
Neck injury, cervical vertigo and 192
Neck pain 815–816
disk-related 815–816 1030–1031 1032–1033
Necrobiosis lipoidica diabeticorum 1225
Necrolysis, toxic epidermal 1596
drugs causing 146 148 1596
Necrophilia 1053
Necrotizing cellulitis, synergistic 1435
Necrotizing fasciitis 1402 1435
cellulitis differentiated from 125
Necrotizing (phlegmonous) gastritis 585
Necrotizing pneumonia 255 1434
Necrotizing ulcerative gingivitis 204
Nedocromil
for allergies 789 790
ophthalmic 175
for asthma 231 233
Needle ablation of prostate, transurethral (TUNA), for benign prostatic hyperplasia 961
Needle-stick injury
hepatitis B vaccine after 1311
HIV infection/AIDS transmission risk and 1319 1333
Nefazodone 1070 1072
Negative-pressure (cuirass) ventilation, intermittent, for COPD 242
Neglect/abuse, of elderly 17 51 54 54 1094
Neighborhood reaction 1294 1295
Neisseria
gonorrhoeae 1431 1552
resistant strains of 1432
meningitidis 1421 1552
resistant strains of 1422
Nelfinavir 1338 1341
resistance to 1345
Nelson's syndrome 1100 1169
Nematode infections 1515–1535
Neoadjuvant chemotherapy 1661
for breast cancer 720
for esophageal cancer 579
for lung cancer 271
Neodymium:yttrium-aluminum-garnet laser photoresection See Nd:YAG laser photoresection
Neologisms, in schizophrenia/psychotic disorders 1057
Neomycin 1572 1573–1574
for hepatic encephalopathy 672
nutrients affected by 1260
for surgical site infection prophylaxis 47
Neonate See Newborn
Neoplasia See Cancer
Neoplastic pericarditis 408
Neostigmine
adverse ocular effects of 178
for myasthenia diagnosis/treatment 1034
Neovascular (rubeotic) glaucoma, retinal vein occlusion and 165
Neovascularization
in diabetic eye disease 167 1221
in retinal vein occlusion 165
Nephrectomy, for renal cell carcinoma 970
Nephritic syndrome 914 914–915 916 917
diseases with nephrotic components and 924–925
in membranoproliferative glomerulonephritis 916 925
Nephritis
interstitial 901 905
lupus 835 916 924
radiation exposure and 1600
tubulointerstitial See Tubulointerstitial diseases
Nephrocalcinosis
in hypercalcemia/hyperparathyroidism 1150 1151
in renal tubular acidosis 889
Nephrogenic diabetes insipidus See Diabetes insipidus, nephrogenic
Nephrolithiasis (kidney/urinary stones) 943–947 944
calcium 943 944 945–946
hypercalcemia/hyperparathyroidism and 944 1150 1150–1151
hypoparathyroidism treatment and 1149
cystine 943 944
indinavir causing 1340–1341
metabolic analysis and 944 944
in polycystic kidney disease 928
in renal tubular acidosis 889 944
in short bowel syndrome 606
struvite 943 946
uric acid 811 930 943 946
Nephronophthisis, juvenile (medullary cystic disease) 927 929
Nephropathia epidemica 1378
Nephropathy
allograft 802
analgesic 926 927
Balkan, ureteral and renal pelvis cancer and 969
contrast 903
diabetic 923 1221–1222
glycemic control and 923 1202 1204 1222
hypertension/hypertension control and 423 425 923 1222
HIV-associated 923
hypercalcemic 879
hypertensive 425 442
IgA (Berger's disease) 915–917 916 917
ischemic 460
lead 926 927
membranous 920 921–922
P.1834
hepatitis C infection and 924
in systemic lupus erythematosus 924
reflux 926 927
urate/uric acid 811 930
cancer-related 1691–1692
Nephrosclerosis, hypertension causing 425
Nephrosis, lipoid (minimal change disease) 920 921
Nephrotic syndrome 914 919–921 920
diseases with nephritic components and 924–925
in HIV infection/AIDS 923
lipid abnormalities and 920 921 1244
lithium causing 1076
in malaria 1487
in membranoproliferative glomerulonephritis 920 924–925
primary renal disorders and 921–922
systemic disorders causing 922–923
Nephrotoxicity See also specific agent
acute tubular necrosis/renal failure caused by 903–904 908
of adefovir 1588
of aminoglycosides 903 1573
of amphotericin B 903 1550 1583
antimicrobial dosage adjustments and 1558–1559
of cisplatin 1685
cyclosporine 903
of foscarnet 1587
of lithium 1076
of mercury 1627
of methotrexate 1684
of NSAIDs 926 927
of sulfonamides 1576
of tetracycline 1571
NERD See Nonerosive reflux disease
Nerve agents, for chemical warfare 1621–1622
skin decontamination and 1611 1622
Nerve biopsy 1023
Nerve block, for pain control, in reflex sympathetic dystrophy 467 822
Nerve conduction velocity studies See Conduction velocity studies
Nervous system 974–1037
assessment of See Neurologic evaluation
disorders of See Neurologic disorders
radiation exposure affecting 1600
syphilis affecting See Neurosyphilis
Nesiritide
for cardiac failure 394
for pulmonary edema 398
NESP See Erythropoiesis-stimulating protein
Netilmicin 1572 1572 1574
therapy adjustments in renal failure and 1572 1573
Neumega (interleukin-11/IL-11), for chemotherapy-induced toxicity 1678
Neural hearing loss 180
eighth nerve lesions causing 180
Neural tube defects
folic acid in prevention of 766–767
prenatal diagnosis of 765
Neuralgia
glossopharyngeal See Glossopharyngeal neuralgia
migrainous (cluster headache) 974 976–977
postherpetic 110 979 1357 1358
trigeminal See Trigeminal neuralgia
Neuralgic amyotrophy (idiopathic brachial plexus neuropathy) 1031
Neuraminidase inhibitors (oseltamivir/zanamivir), for influenza prevention/treatment 1353 1384 1586
Neuritis
intercostal 344
optic 169
Neuroblastoma, chemotherapy for 1665
Neuroborreliosis 1460 1462
Neurocardiogenic (vasovagal/vasomotor) syncope 313 384
Neurocutaneous diseases 1006
Neurocysticercosis 1510–1511 1511 1512
Neurodermatitis, circumscribed (lichen simplex chronicus) 97
Neuroendocrine tumors 1178–1179
in multiple endocrine neoplasia 1191
Neurofibromas 999 1006
Neurofibromatosis 1006
Neurogenic arthropathy (Charcot's joint) 862
in diabetes mellitus 862 1223
in tabes dorsalis 862 1451
Neurogenic hyperventilation, in coma or stupor 305 1018
Neurogenic shock 478–479 478 479
Neuroimaging
in brain abscess 1004
in cerebral infarction 993
in cysticercosis 1511
in dementia 57
in head injury 1019
in headache 32–33 32
in intracerebral hemorrhage 995
in intracranial aneurysm 996
in intracranial arteriovenous malformations 998
in intracranial mass lesions 1001
in multiple sclerosis 1015
in psychiatric disorders 1040 1058
in seizures 982
in subarachnoid hemorrhage 995–996
Neuroleptic malignant syndrome 26 1063 1610 1633
Neuroleptics See Antipsychotic drugs
Neurologic deficits
back pain and 817 818 818 819
in brain abscess 1004
cerebral arteriovenous malformations causing 997
in cerebral infarction 991–993
in intracerebral hemorrhage 995
in intracranial aneurysms 996
intracranial mass lesions causing 1001
false localizing signs and 1001
in migraine headache 975
in paraneoplastic syndromes 1004–1005 1695–1698
spinal cord arteriovenous malformation causing 999
spinal cord tumors/compression causing 1003
spinal trauma causing 1021
in subarachnoid hemorrhage 995
in transient ischemic attacks 988
Neurologic disorders 974–1036
in African trypanosomiasis 1464
coxsackieviruses causing 1389
in cryptococcosis 1543
in cysticercosis 1510–1511 1511 1512
cytomegalovirus causing 1361
dysautonomia caused by 987
in Gaucher disease 1706
headache and 974
in HIV infection/AIDS 1320 1324–1325
hypernatremia treatment and 871
infection 1293–1295 1294
anaerobic 1434–1435
in leprosy 1025 1439
in loiasis 1526
in Lyme disease 1026 1458 1459 1461
measles virus causing 1363
in near drowning victim 1603
in paragonimiasis 1507
paraneoplastic 1004–1005 1695–1698
in porphyria 1703
postoperative 44 44
primary angiitis 851
radiation exposure and 1600
in renal failure 910–911
respiratory failure caused by 307
syndrome of inappropriate ADH secretion caused by 868
in systemic lupus erythematosus 835 835
thiamin deficiency causing 1272–1273
in thrombotic thrombocytopenic purpura 521
in Wilson's disease 678 1013
Neurologic evaluation
in back pain 818
in dementia 57
preoperative 44 44
in psychiatric disorders 1040
Neurologic surgery See Neurosurgery
Neuroma/neurinoma, acoustic (vestibular schwannomas/eighth nerve tumors) 193–194 1000
hearing loss and 180 193 1000
in neurofibromatosis 1006
Neuromuscular disorders
cancer-related 1696
respiratory failure caused by 307
Neuromuscular transmission disorders 1031–1035
Neuromyotonia 1102
Neuronal neuropathies 1023
Neuronitis, vestibular 191
Neuronopathy, bulbospinal X-linked 1022
Neuropathic bladder, vincristine-induced 1684
Neuropathic pain 79–80 79 1024
Neuropathies 1023–1031
alcoholism and nutritional deficiency and 1025
autonomic
cancer-related 1005
in diabetes 1224
dysautonomia and 987
vincristine-induced 1684
brachial plexus 1031
cancer-related 1005 1026 1695–1698 1696
chemotherapy-induced 1683–1684
compression See Entrapment/compression neuropathy
in critically ill patient 1026
diabetic 1198 1222–1225
clinical studies of glycemic control and 1202
foot ulcers/gangrene and 1223 1225
didanosine therapy and 1325 1339
diphtheritic 1026 1413
dysautonomia and 987
entrapment See Entrapment/compression neuropathy
P.1835
facial 1029
hereditary motor and sensory (HMSN), types I to IV 1024
in HIV infection/AIDS 1026 1325
infectious/inflammatory disease and 1025–1026
inherited 1024–1025
in leprosy 1025 1439
in Lyme disease 1026 1458–1459 1459
metabolic/systemic disease and 1025
in myeloma 1025
nutritional 1025
optic, anterior ischemic 169
giant cell arteritis and 169 846
in paraproteinemias 1025
peripheral See also specific type
in polyarteritis 845 1026
in porphyria 1024–1025 1703
in renal failure/uremia 911 1025
in rheumatoid arthritis 828 1026
in sarcoidosis 1026
stavudine therapy and 1325
in thiamin deficiency 1025 1273
toxic 1026
in vitamin B12 deficiency 487 1025
Neuropeptide Y
in obesity 1098
in pheochromocytoma 1174
Neuropsychologic assessment 1040
in dementia 57
Neuroses, Sunday 1043
Neurosurgery
antibiotic prophylaxis for 47
venous thrombosis/pulmonary embolism prevention and 286 287
Neurosyphilis 1443 1444 1448 1450–1452 1557
cerebrospinal fluid examination in 1446 1449 1451 1452
in HIV infection/AIDS 1332 1452
Neurotoxicity
of aminoglycosides 1573
of chlorinated insecticides 1622
of cisplatin 1685
of snake venom 1635
Neurotransmitters See also specific type
in substance abuse disorders 1082
Neurotropic disease
viral 1369–1376
yellow fever vaccine-associated 1315
Neutral protamine Hagedorn (NPH) insulin See Insulin therapy; NPH insulin
Neutral protamine lispro (NPL) insulin 1213 1215
Neutrexin See Trimetrexate
Neutrocytic ascites 561
Neutrogena 90
Neutropenia 498–499 499 1555
in acute leukemia 508
fever/FUO and 499 1286 1287 1555 1695
gram-negative bacteremia and sepsis and 1423
granulocyte transfusion for 535
infections and 498 499 1555
in cancer patients 1289 1555 1694–1695
prevention/treatment and 499 1290 1555 1694–1695
Neutrophil count See also Neutropenia; Neutrophilia
laboratory reference range (normal values) for 1741
Neutrophilia
in cellulitis 125
in gram-negative bacteremia and sepsis 1423
Nevi 143
atypical (dysplastic) 93
blue 93
compound 93
congenital 93
junctional 93
spider, in cirrhosis 669
Nevirapine 1338 1341–1342 1343
resistance to 1345
Nevus See Nevi
New variant Creutzfeldt-Jakob disease 1374–1375
New World cutaneous leishmaniasis 1480 1484–1485
Newborn
antiretroviral/zidovudine therapy for 776 1333
CMV inclusion disease in 1360
group B streptococcal infection in 780 1402
hemolytic disease of, prevention of 783
hepatitis B transmission/vaccine and 653 657 1311
hepatitis C transmission and 655
herpes simplex infection and 778
HIV transmission to 776 1333
listeriosis in (granulomatosis infantisepticum) 1414
maternal thyroid disease and 1131 1142
rubella infection and 1368 1369
syphilis in (congenital syphilis) 1443 1453
toxoplasmosis during pregnancy and 1498 1500 1501
NH3 See Ammonia
Niacin (vitamin B3) 1273–1274
dietary reference intakes (DRIs) for 1254
for lipid modification/heart disease prevention 1249 1251 1273–1274
mental changes associated with deficiency of 1103 1274
Niacinamide 1274
Nicardipine 436
for hypertensive urgencies/emergencies 443 445
overdose/toxicity of 1621
Niclosamide, for tapeworm infection 1509
Nicoderm See Nicotine, for replacement therapy in smoking cessation
Nicotinamide See also Niacin
for niacin deficiency 1274
Nicotine See also Smoking
acupuncture for withdrawal from 1726 1729
breast feeding and 786
for replacement therapy in smoking cessation 7 8 9 10
Nicotinic acid See Niacin
Nicotrol See Nicotine, replacement therapy for smoking cessation
Nifedipine
for hypertension 436
urgencies/emergencies 444 445
MAOI-induced 1073
overdose/toxicity of 1621
Nifurtimox, for Chagas' disease 1466–1467
Night blindness, in vitamin A deficiency 1276
Nightmares 1080
Nikolsky's sign 126
Nil disease (minimal change disease) 920 921
Nilutamide 1673
Nimodipine See also Calcium channel blocking drugs
overdose/toxicity of 1621
Nipah virus 1376
Nipple, Paget's carcinoma involving 107–108 713
Nipple discharge 703–704
in breast cancer 704 713
in fibrocystic breast condition 702 704
in male 726
Nipride See Nitroprusside
Nisoldipine 436
overdose/toxicity of 1621
Nitazoxanide, for giardiasis 1480
Nitrates See also Nitroglycerin
for acute coronary syndromes 352–353
for angina
for acute attack 348
prophylactic administration of 348
for cardiac failure 394
infarct-associated 363
for esophageal varices, prevention of rebleeding and 575–576
for myocardial infarction 360
for pulmonary edema 398
Nitric oxide, burn injury and 1596
Nitric oxide synthetase, burn injury and 1596
Nitrites
for cyanide poisoning 1611 1623 1623
in urine 934–935
Nitrofurantoin 1582
nutrients affected by 1260
for urinary tract infection 939 1582
Nitrogen, liquid See Liquid nitrogen
Nitroglycerin See also Nitrates
for acute coronary syndromes 352–353
for anal fissures 647
for angina
for acute attack 348
in diagnosis 343
prophylactic administration of 348
for cardiac failure 394
infarct-associated 363
for hypertensive urgencies/emergencies 442 443
for myocardial infarction 360
phosphodiesterase inhibitor/sildenafil contraindications and 454 952 1224
prophylactic intraoperative administration of 38
Nitroprusside
for cardiac failure 394
cyanide poisoning caused by 1623
for hypertensive urgencies/emergencies 442 443
Nix See Permethrin
Nizatidine 588–589
Nizoral See Ketoconazole
Njovera (endemic syphilis) 1454
NK cell lymphoma, nose and paranasal sinus involvement and 201
NLP See No light perception
N,M-diethyl-3-methylbenzamide mosquito repellent (DEET) 1488
NMS See Neuroleptic malignant syndrome
NNRTIs See Nonnucleoside reverse transcriptase inhibitors
No light perception (visual acuity) 151
Nocardia (nocardiosis) 1436–1437 1554
actinomycotic mycetoma caused by 1547
asteroides 1436 1437
brasiliensis 1437
sulfonamides for 1576
P.1836
Noctec See Chloral hydrate
Nocturia 932
in cardiac failure 388
malabsorption and 600
Nocturnal dyspnea 218
in heart disease 313
Nocturnal leg cramps 1102
Nocturnal myoclonus 1080
Nocturnal penile tumescence testing 951
Nodular (multinodular) goiter 1120 1122
toxic 1140–1141
Nodular malignant melanoma 94
Nodules
milkers' (paravaccinia) 1388
pulmonary, solitary See Solitary pulmonary nodule
rheumatoid 827 828
gouty tophi differentiated from 812 828
skin 92
in filariasis 1522
inflammatory 137–139
violaceous to purple 131–132
subcutaneous See Subcutaneous nodules
thyroid 1119–1122 1120
vocal cord 210
laryngitis and 210
Noise trauma
explosive, tympanic membrane perforation caused by 187
hearing loss caused by 180 181 187 188
Nolvadex See Tamoxifen
Non-ABCDE hepatitis, transfusion-associated 652
Nonadherence See Compliance/noncompliance
Nonalcoholic fatty liver disease (NAFLD) 667–668
cirrhosis and 668 669
Nonalcoholic steatohepatitis (NASH) 667
Nonbacterial prostatitis 941–942 942
Noncirrhotic portal hypertension 680
Nonclostridial crepitant cellulitis 1435
Noncompliance See Compliance/noncompliance
Nonconvulsive status epilepticus 986
Nondysenteric colitis 1468 1470 1471
Nonerosive/nonspecific gastritis 584–585
Nonerosive reflux disease 566
Nonfamilial adenomatous polyps 633–635
Nongonococcal acute bacterial arthritis See Septic (nongonococcal acute bacterial) arthritis
Non-group A streptococcal infections 1402 1552
Non-Hodgkin's lymphoma 512–514 513 1663
chromosomal abnormalities in 512
fever caused by 1287
gastric 598–599
Helicobacter pylori infection and 584 598–599 1644
in HIV infection/AIDS 1000 1003 1323 1328 1335 1644
incidence/mortality of 1640
intestinal 610–611
nose and paranasal sinus involvement and 201
thyroid 1124 1129
Noninsulinoma pancreatogenous hypoglycemic syndrome (persistent islet hyperplasia) 1237
Noninvasive positive-pressure ventilation (NPPV)
for COPD 242
for respiratory failure 308
Nonketotic hyperglycemic hyperosmolar coma See Hyperglycemic hyperosmolar state
Nonmyeloablative allogeneic peripheral blood stem cell transplantation 1661
Nonnucleoside reverse transcriptase inhibitors (NNRTIs) 1338 1341–1342
antituberculous drug interactions and 261
in combinations 1342 1343
resistance to 1345
Nonoxynol 9, HIV infection/AIDS and 1331
Nonparalytic poliomyelitis 1366 1367
Nonparoxysmal junctional tachycardia 379
Nonpigmented (amelanotic) melanoma 94
Non-Q wave infarction See Myocardial infarction; Non-ST elevation (non-Q wave) infarction
Non-rapid eye movement (non-REM) sleep 1078
Nonscarring alopecia 144–145
Nonsecretory myeloma 516
Nonseminomas 971 972 1182
Non–small cell lung cancer 267
paraneoplastic syndromes associated with 1696–1697
staging of 268 269
survival rates for 272 272
treatment of 270–271 1664
Nonspecific interstitial pneumonia/pneumonitis (NSIP) 276–278 277
in HIV infection/AIDS 1323
Non-ST elevation acute coronary syndromes 352
Non-ST elevation (non-Q wave) infarction 355 356
thrombolysis contraindicated in 358
Nonsteroidal anti-inflammatory drugs (NSAIDs) 74 75–76 830–831
for abnormal premenopausal bleeding 729
in analgesic nephropathy 926 927
for ankylosing spondylitis 853
in cancer prevention 638 1648 1650 1700
in elderly 65
gastritis caused by 583
gastrointestinal bleeding associated with 74 556 830
for gout 812
hypertension and 422
in microscopic colitis 631
nephrotoxicity of 926 927
for ophthalmic disorders 174–175
for osteoarthritis 810
for pain management 74 75–76
with opioid analgesics 74 78
in peptic ulcer disease 586–587 589–591 590
misoprostol coadministration and 589 591 830
prevention and 587 589 590–591 830
platelet function affected by 526 830–831
prerenal azotemia caused by 830 901
for rheumatoid arthritis 830–831
topical 88
Nonsustained ventricular tachycardia 380
Nontreponemal antigen tests, for syphilis 1444–1445 1444
Nontuberculous (atypical) mycobacteria (NTM) 1437–1438
adenitis/lymphadenitis/scrofula caused by 215–216 1438
MAC infections See Mycobacterium (mycobacterial infections), avium complex
pulmonary disease caused by 263–265 1437–1438
in HIV infection/AIDS 264 1323
skin and soft tissue infections caused by 1438
Nonulcer (functional) dyspepsia 536 537–538
Nor-QD See Progestins
Norelgestromin, in transdermal contraceptive patch 754
Norepinephrine, in pheochromocytoma 1174
Norethindrone
for abnormal premenopausal bleeding 729
in combination oral contraceptives 751–752
for postmenopausal vaginal bleeding 730
in progestin minipill 752 753
Norflex See Orphenadrine
Norfloxacin 1580 1581
for ophthalmic disorders 175
for urinary tract infection 939
Norgestimate, in combination oral contraceptives 752
Norgestrel
in combination oral contraceptives 751–752
in progestin minipill 752 753
Normal anion gap acidosis See Hyperchloremic normal anion gap acidosis
Normal flora, anaerobic infections caused by 1434 1435
Normal-pressure hydrocephalus 1020
Normal ranges, for diagnostic/laboratory tests 1735–1743
Normal-tension glaucoma 160 161
Normodyne See Labetalol
Normokalemic periodic paralysis 1037
Norplant system 754
Norpramin See Desipramine
Nortriptyline 1071 1072
monitoring concentrations of 1071 1734
for neuropathic pain/diabetic neuropathy 79 1223
Norvasc See Amlodipine
Norvir See Ritonavir
Norwalk virus/Norwalk-like viruses 1299 1389
Nose 194–202
infections of 194–197
traumatic injury of 199–200
tumors/granulomatous disease of 200–202
Nosebleed See Epistaxis
Nosocomial infections 1291–1293
coagulase-negative staphylococci causing 1408
fever of unknown origin and 1286
parvovirus B19 1387
pneumonia 253–255 1555
respiratory syncytial virus 1382
urinary tract 936 1292
Novel erythropoiesis-stimulating protein (NESP/darbopoetin), for chemotherapy-induced toxicity 1678 1681
Novolin 1212 1213
Novolog See Insulin aspart
NPH1/NPH2/NPH3 genes, in juvenile nephronophthisis-medullary cystic disease 929
P.1837
NPH insulin 1212 1213 1214 1214
in mixtures/combination therapy 1213 1215 1218 1219
NPL insulin 1213 1215
NPPV See Noninvasive positive-pressure ventilation
NREM sleep 1078
NRTIs See Nucleoside reverse transcriptase inhibitors
NSAIDs See Nonsteroidal anti-inflammatory drugs
NSCLC See Non-small cell lung cancer
NSIP See Nonspecific interstitial pneumonia/pneumonitis
NSVT See Nonsustained ventricular tachycardia
NTM See Nontuberculous (atypical) mycobacteria
NTZ See Nitazoxanide
Nuclear bleeding scans, in lower gastrointestinal bleeding 556
Nuclear terrorism 1601
Nuclear transcription factor mutations, in maturity-onset diabetes of the young (MODY) 1195 1197
Nucleic acid amplification tests, in tuberculosis 258
Nucleic acid probes See also DNA probes
in viral infection 1349–1350
Nucleoside reverse transcriptase inhibitors (NRTIs) 1337 1339–1340
in combinations 1342 1343
for hepatitis B 660
resistance to 1344
Nucleotide reverse transcriptase inhibitor 1337 1340
in combinations 1342 1343
for hepatitis B 660 1340
resistance to 1344
Nucleus pulposus, herniation of
cervical 815–816 1030–1031 1032–1033
lumbar/sacral 817 818 818 819
NuLytely See Polyethylene glycol
Numorphan See Oxymorphone
Nursing (breast feeding) See Lactation
Nursing homes, tuberculosis/tuberculosis testing in elderly and 55 257
Nutcracker esophagus 581
NutraSweet See Aspartame
Nutrients See also Diet; Nutrition; Nutritional disorders
absorption/digestion of 601
assessment/clinical signs of deficiencies of 1263–1264 1264 1265
diets restricting 1278–1279
diets supplementing 1279
drug interactions and 1259 1260
requirements for 1253–1263 1254–1255 1256 1257
in nutritional support 1281–1282
Nutrition 1253–1285
assessment of 1263–1264 1264 1265
dietary guidelines and 3 1259–1263 1261–1262
in elderly 64
nutrient requirements and 1253–1263 1254–1255 1256 1257
nutritional support and 1281–1282
in pregnancy 764 766–767 1254 1256 1257
in renal failure 911–912
for terminally ill/dying patient 82
Nutritional disorders 1264–1270
assessment of 1263–1264 1264 1265
cognitive disorders/delirium caused by 1091
diet therapy for 1277–1280
lactic acidosis and 887
neuropathy associated with 1025
Nutritional support 1280–1285
in alcoholic liver disease/cirrhosis 665 670
for anorexia nervosa 1271
in burn injury 1598
in Crohn's disease 624–625
in elderly 64
in HIV infection/AIDS 1322
indications for 1280
for involuntary weight loss 29
nutrient requirements for 1281–1282
patient monitoring during 1285
for protein-energy malnutrition 1266
in respiratory failure 308–309
selection of method for 1280–1281 1281
in short bowel syndrome 606
for terminally ill/dying patient 82
Nylen-B r ny maneuvers 190
Nystagmus 152
in coma or stupor 1018
intracranial mass lesions causing 1001
in vertigo 190 192
Nystatin 1583
for candidiasis 1583
vaginal 732
EAN: 2147483647
Pages: 71